News
-
-
-
PRESS RELEASE
Capital B announces the entry into force of the reverse stock split of its shares at a ratio of 10 existing shares for 1 new share
Capital B implements a 10:1 reverse stock split to enhance institutional development & investor reach. Details on adjusted terms provided. Effective from September 8, 2026 -
-
-
PRESS RELEASE
Transgene and ProBioGen Expand Strategic Partnership with Additional License Agreement for AGE1.CR.pIX Cell Line
Transgene and ProBioGen announce expanded partnership with additional license agreement for AGE1.CR.pIX cell line, enhancing manufacturing capabilities for vaccine production -
-
-
-
PRESS RELEASE
Sandoz hosts Capital Markets Day and unveils Bio100 ambition – maximising Sandoz value in its golden decade for biosimilars
Sandoz hosts Capital Markets Day unveiling Bio100 ambition to maximize value in golden decade for biosimilars. Strong growth plan aims for 100+ biosimilars by 2040